chitosan has been researched along with Brain Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, OY; Ameen, AER; Nafee, N | 1 |
| Feng, J; Hu, K; Liu, M; Xu, X; Yu, S | 1 |
| Abdallah, OY; Abdelmonsif, DA; Elnaggar, YS; Etman, SM | 1 |
1 review(s) available for chitosan and Brain Diseases
| Article | Year |
|---|---|
Chitosan and chitosan coating nanoparticles for the treatment of brain disease.
Topics: Animals; Biological Availability; Blood-Brain Barrier; Brain Diseases; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Permeability; Tissue Distribution | 2019 |
2 other study(ies) available for chitosan and Brain Diseases
| Article | Year |
|---|---|
Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats.
Topics: Administration, Intranasal; Alginates; Animals; Brain; Brain Diseases; Chitosan; Drug Delivery Systems; Hydrogels; Hypromellose Derivatives; Male; Rats; Temperature; Vinca Alkaloids | 2020 |
Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
Topics: Administration, Intranasal; Alkaloids; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Benzodioxoles; Brain Diseases; Caspase 3; Chitosan; Cholinesterase Inhibitors; Cognition; Drug Delivery Systems; Male; Nanoparticles; Particle Size; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |